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Abstract
Background: Starting with early identification of palliative care patients by general practitioners (GPs), the Care
Pathway for Primary Palliative Care (CPPPC) is believed to help primary health care workers to deliver patient- and
family-centered care in the last year of life. The care pathway has been pilot-tested, and will now be implemented
in 5 Belgian regions: 2 Dutch-speaking regions, 2 French-speaking regions and the bilingual capital region of
Brussels. The overall aim of the CPPPC is to provide better quality of primary palliative care, and in the end to
reduce the hospital death rate.
The aim of this article is to describe the quantitative design and innovative data collection strategy used in the
evaluation of this complex intervention.
Methods/Design: A quasi-experimental stepped wedge cluster design is set up with the 5 regions being
5 non-randomized clusters. The primary outcome is reduced hospital death rate per GPs’ patient population. Secondary
outcomes are increased death at home and health care consumption patterns suggesting high quality palliative care.
Per research cluster, GPs will be recruited via convenience sampling. These GPs -volunteering to be involved will recruit
people with reduced life expectancy and their informal care givers. Health care consumption data in the last year of
life, available for all deceased people having lived in the research clusters in the study period, will be used for
comparison between patient populations of participating GPs and patient populations of non-participating GPs.
Description of baseline characteristics of participating GPs and patients and monitoring of the level of involvement by
GPs, patients and informal care givers will happen through regular, privacy-secured web-surveys.
Web-survey data and health consumption data are linked in a secure way, respecting Belgian privacy laws.
Discussion: To evaluate this complex intervention, a quasi-experimental stepped wedge cluster design has been set
up. Context characteristics and involvement level of participants are important parameters in evaluating complex
interventions. It is possible to securely link survey data with health consumption data. By appealing to IT solutions we
hope to be able to partly reduce respondent burden, a known problem in palliative care research.
Trial registration: ClinicalTrials.gov Identifier: NCT02266069.
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Background
Importance of primary palliative care
Although palliative care pioneers had the desire to give a
dignified death to all people, their efforts focused mainly
on symptom control in cancer patients. Nowadays, a
more comprehensive, community-oriented, population-
based and public-health approach is developed by the
palliative care community [1] and supported by the
World Health Organization [2].
This comprehensive approach cannot be realized by pal-
liative care specialists alone. General practitioners (GPs)
express their interests in being involved in high quality
palliative care for all people aiming to stay at home in
their last phase of life [3]. This requires training the GPs
in (generalist) palliative care, and offering them advice
from a palliative care specialist when needed [4, 5].
Quill & Abernethy describe which roles both parties
should take in this collaboration [6]. Well-functioning
second-line palliative care networks who are collaborat-
ing with GPs and go to a patient’s home only on occa-
sion have proven to lead to desirable outcomes [7, 8].
Good inter-professional collaboration between special-
ized palliative care teams and primary care professionals
often leads to workplace learning, in which both parties
can absorb each other’s expertise and experience [9].
Challenges and opportunities for palliative care research
in primary care
Several challenges are known in both palliative care re-
search and primary care research. The key challenges for
palliative care research are mainly related to the functional
decline and suffering experienced by palliative care pa-
tients, leaving little room for performing extra tasks like
participation in research. There is also the already high
care burden for family members and the gate keeping
function of health care professionals willing to protect pa-
tients and their family from respondent burden [10].
The key challenges in primary care research are that
primary care teams are geographically dispersed, with
per practice a small amount of patients possibly suitable
for any study. Furthermore, every primary care practice
participating in research has to go through four stages,
with their own challenges: from (1) the agreement of the
professional to participate to (2) actual participation of
professionals, (3) patient agreement and (4) finally patient
data collection [11].
Palliative care research in the primary care setting is
thus expected to face double challenges: the gate keep-
ing role of practitioners is suspected to be even stronger
here [12]. Advances in electronic management of routine
clinical data could have important implications for re-
cruitment if concerns about confidentiality can be satis-
factorily addressed. Both for observational and cohort
studies and for trials requiring the consent of individual
participants, the electronic health record could enable
researchers to follow participants more easily followed
over time [11]. These ideas lead to the concept of the
Learning Health Care System, in which routinely col-
lected clinical data inform research and practice-based
research informs on its turn clinical service [13, 14].
Setting
In Belgium, community-based specialist palliative care
teams support GPs and other primary care workers con-
fronted with complex palliative care situations. Palliative
care networks (PCNs) have the assignment to teach
health care professionals and to inform lay-people about
palliative care principles, to teach and coach palliative
care volunteers and to collect analyzable data on pallia-
tive care in their territory. Related to these networks,
palliative home care teams, including experienced physi-
cians, nurses, psychologists and/or social workers, advise
primary care professionals dealing with concrete pallia-
tive care patients at home or in residential care settings
(e.g. nursing homes and institutions for people with dis-
abilities). Palliative home care teams aim to complement
the generalist palliative care approach of primary care
workers by specialist palliative care activities [7, 8].
For the scope of this article, it is also relevant to know
about some practicalities of the Belgian health care system.
Every person with a legal stay in Belgium has a National
Registry Number (NN). This NN can be used to uniquely
identify all people entering the health care system. All data
on reimbursed health care consumption are linked to this
personal NN. Health insurance is organized by 7 different
health insurance funds (HI funds). Every person with a legal
stay in Belgium is obliged to choose membership of 1 of
those HI funds. Primary healthcare is mainly paid fee for
service of which 75 % (or more in specific cases) is reim-
bursed afterwards by the HI funds. These institutions are
independent organizations receiving their main income
from the National Institute for Health and Disability Insur-
ance (NIHDI). The different HI funds constitute the Inter-
Mutualistic Agency (IMA) to bring together electronically
all the health care consumption data from all Belgian in-
habitants for research purposes.
All registered health care professionals have their own
NIHDI-number, comparable to NN for citizens. Most
Belgian GPs work in a mono-disciplinary GP practice and
on a fee-for-service basis. Many GPs work in single-
handed practices. GPs are increasingly organizing them-
selves in group practices, which are sometimes supported
by paramedical personnel and are seldom organized in a
forfeit payment system. In 2012, 2,7 % of all Belgian pa-
tients were served by practices in this forfeit payment sys-
tem, mostly multi-disciplinary group practices [15]. All
people are free to choose their GP and GPs are free to
accept or refuse patients. Because of this freedom of choice,
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there are no inscription lists, complicating practice denom-
inator calculations. A financial measure with small benefits
for both GPs and patients is encouraging patients’ fidelity
towards the GP chosen by the patient. Professional guide-
lines on different (primary care) topics were compiled, pub-
lished and updated regularly but are not compulsory.
GP circles, GP associations at meso-level, are important
partners for change in the Belgian general practice land-
scape. These professional associations unite the local GPs,
mostly 70 to 100 GPs. The two main goals of a local GP-
circle are to organize out-of-hours primary care services
and continuing medical education.
The Care Pathway for Primary Palliative Care (CPPPC)
The development of the CPPPC should be seen in the
context of trying to fulfill the educational needs of pri-
mary health care professionals in ‘basic’ palliative care
skills [6]. The palliative care community has bad experi-
ences with another Care Pathway, the Liverpool Care
Pathway [16]. Of the 44 recommendations of its inde-
pendent evaluation report [17] the most relevant for this
project is number three: “The name ‘Liverpool Care
Pathway’ should be abandoned, and within the area of
end of life care, the term ‘pathway’ should be avoided. An
‘end of life care plan’ should be sufficient for both profes-
sionals and lay people.”
Still, our research group decided to keep the name of
the intervention as a Care Pathway. Currently, there is a
movement to integrate patient-centeredness more expli-
citly into the development, implementation and evalu-
ation of care pathways [18, 19] – this CPPPC could be
an example of how to (try to) do that, because of the im-
portance it gives to the preferences of individual patients
included in the Care Pathway.
The Palliative Care Research Group of the University
of Antwerp developed and pilot-tested this care pathway
in collaboration with the Flemish Federation of Palliative
Care and the Belgian Dutch Care Pathway Network,
with funding of the Flemish Government [20, 21]. The
CPPPC is inspired by the philosophy of the 7C’s of the
Gold Standard Framework [22]. Its components are
summarized in Table 1.
GPs interested in implementing the CPPPC are taught
about the four pillars in the development of care path-
ways: (1) research evidence, (2) clinical expertise, (3) local
organization of care and use of tools and resources and
(4) patient preferences [23]. The CPPPC is presented to
GPs as bringing the first two pillars. Each GP should attri-
bute the two other pillars, i.e. how he or she organizes the
delivery of palliative care and his or her perception of how
to handle concrete patient and their relatives.
For the implementation study we will be performing,
the CPPPC focuses on the following aims:
1. Early identification of palliative care patients: GPs are
asked to answer the “surprise question” (“Would you
be surprised if the patient would die within a year?”)
aiming to comprise a list of people with reduced life
expectancy [24]. It is expected that this step will lead
to earlier identification of palliative care patients than
happens in usual care [25].
2. GPs introducing Advance Care Planning to these
early palliative care patients: it is only when GPs
share a certain awareness with the patient about the
need for discussion of end-of-life care issues that
GPs are considered to be able to start discussing
Advance Care Planning with patients. To facilitate
this step, recommendations for breaking bad news are
taught in the educational sessions and are available at
www.pro-spinoza.be in Dutch and French. It is
expected that this step will lead to more awareness of
both professionals, patients and family members of
end-of-life care goals and that these goals will be more
often attained.
3. Delivery of high quality palliative care: GPs are
expected to deliver optimal quality of palliative care
which could be achieved by three instruments
suggested by the CPPPC: (1) the ‘palliative care
pathway’-file, (2) the Palliative Performance Scale
(PPSv2) [26], and (3) a manual on primary palliative
care in Belgium, all available at www.pro-spinoza.be
in Dutch and French. This ‘palliative care pathway’
has been designed to facilitate communication
within the team of health professionals around the
patients and between the health care team, the
patients and the informal care givers, including
among others a page listing issues on physical,
psychological, social and existential issues within
Table 1 Components of the Care Pathway for Primary Palliative
Care
1. Early identification of patients eligible for palliative care, using the
Surprise Question [21] and/or the Supportive and Palliative Care
Indicator Tool (SPICT) [28]
2. Early assessment of patient’s needs and wishes
a. Assessment of performance status, using the Palliative Performance
Scale (PPSv2) [22, 23]
b. Assessment of the patient’s needs in the biological, psychological,
social and existential aspects of his or her life
c. Advance care planning
3. Interdisciplinary discussion
4. Action: delivering palliative care
5. Registration in a ‘palliative care pathway’ file, common for all team
members
6. Follow-up by the team, recognizing the different stages in the palliative
continuum: the ‘early palliative’ stage (the patient cannot be cured
anymore), the ‘transitional’ stage (the last months) and at last the ‘dying’
stage (the last few days)
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palliative care. The PPSv2 can help to detect
milestones in prognosis: for instance, in cancer
patients, it is known that a PPSv2 score of 60 % is
correlated with a mean survival time of 92 days [27].
It is expected that this step will lead to higher
patient and informal caregiver satisfaction, reduced
number of hospital admissions as well as length of
hospital stay in the last year of life besides a reduced
hospital death rate.
4. Ensuring high quality care for the dying and for the
bereaved: GPs are taught about warning signs
(PPSv2 score of 20 % or lower) for the dying phase
of patients and about good clinical practice in
palliation. It is expected that this step will lead to a
higher level of satisfaction with care for the dying
and the bereaved.
The implementation of the CPPPC in five clusters in
Belgium
After the development of the CPPPC, the next step is to
establish and document the implementation of this care
pathway. The implementation was to be rolled out in
five clusters.
Using a stepped-wedge cluster design, the authors will
be able to closely guide the starting-up of the implemen-
tation of the CPPPC in all five clusters. The implementa-
tion scenario per cluster is summarized by Table 2, but
can be adapted to the specific needs of each cluster.
The evaluation of the implementation of the CPPPC
The overall aim of this study is to evaluate whether the
regional implementation of the CPPPC leads to an im-
proved quality of palliative care in a region, seen from
different perspectives: (1) of the people with limited life
expectancy and their informal caregivers, (2) of GPs and
(3) of the NIHDI as the national health care financing
organization.
The specific objectives of this study are (1) a reduction
of hospital death rate (primary outcome), (2) directing use
of services during the last year of life towards quality-of-
life (secondary outcome), (3) monitoring quality of life be-
sides quality of care as perceived by patients, informal care
givers and GPs (descriptive), (4) monitoring the level of im-
plementation of the CPPPC by the GPs (descriptive) and
(5) understanding in which circumstances (how and why)
the implementation of the CPPPC works or does not work.
The theoretical framework guiding this evaluation
study, is the framework of Grol and Wensing, describing
five areas with possible barriers and facilitators for im-
plementation of innovations in the health care system:
the innovation itself, the targeted patients, the individual
professionals, the social context, the organizational con-
text, and the economic and political context [28].
Farquhar et al. state that a mixed methods study de-
sign is appropriate to develop and evaluate the imple-
mentation of complex interventions in palliative care [9].
The CPPPC being such a complex intervention, it has
been decided to triangulate quantitative and qualitative
research methods to evaluate this Belgian quality im-
provement project in primary palliative care.
Aims of this article
For this methodological article, the focus is on the first
four specific objectives of the study. In order to be clear
on the quantitative methods used in this study, measure-
ments of process and outcome indicators for the imple-
mentation of the CPPPC on GP, patient and informal
care giver level are explained. In order to encourage
other palliative care researchers to use large data sets
linked with survey data, the privacy-respecting data
handling procedures are explained.
The qualitative methods (focus groups, interviews,
document analyses) used to obtain the fifth specific ob-
jective of the study will be explained in a future article.
Methods/Design
The stepped wedge cluster design (quasi-experimental)
For this study, a cluster design with a “stepped wedge”
approach was chosen. This type of trial design involves
sequential roll-out of an intervention to clusters over a
number of time periods. The order in which clusters
start the intervention is determined at random. In the
end, all clusters will have started the intervention. This
trial design is particularly interesting 1) when a certain
intervention cannot be started simultaneously in all clus-
ters, for instance because of logistical or financial rea-
sons and 2) when researchers want to prevent ethical
objections arising from withholding an intervention an-
ticipated to be beneficial [29].
Five clusters will be involved (Table 3). The implemen-
tation of the CPPPC will be initiated in all clusters, in a
stepped way. Ideally, to reduce bias, the different clusters
need to be randomized from the start of the project.
However, in this particular study, it was impossible to
Table 2 Implementation scenario per region
1. Finding a palliative care network willing to participate
2. Asking the GP circles within the territory of the palliative care network
to promote this project to their member GPs
3. Organizing a ‘kick-off’ workshop and other educational sessions to
motivate individual GPs to participate in this project, explaining the
CPPPC and training the GPs to obtain an informed consent of
palliative care patients
4. Organizing an inter-professional platform where representatives of
both the palliative care network and the GP-circles meet every six
months to evaluate the regional implementation strategy
5. Inviting representatives of the inter-professional platform of the region
to an interregional platform every year, to enable them to learn from
the experiences of the other regions
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randomize the order of the regions from the beginning.
Not all 5 clusters were well defined at the start of the
project. Whenever we found a region’s palliative care
network ready to participate, we offered that region the
choice to start in the next phase, regardless of any pref-
erences as a research team. That is why this study
should be called a quasi-experimental study based on a
stepped wedge cluster design.
Stepped wedge cluster procedure
It was decided to have phase intervals of six months,
starting from the 1st of April 2013. The first phase is a
‘usual care’ phase for all the clusters. Every next phase,
the intervention will be started in one cluster. The last
intervention phase (phase 6) lasts until the 31st of
March 2016. After this last date, no more ‘interventions’
on behalf of the study will be undertaken: neither meet-
ings or educational sessions or recruitment of GPs and
patients for the study.
A post-intervention data collection period for included
patients will follow. This period (phase 7) lasts for
33 months, enabling the authors to cope with the effect
delay of the intervention: patients will probably not all
die in the same phase they were included in the study.
Data collection will stop the 31st of December 2018.
A time schedule of the ‘stepped wedge cluster design’
is shown below (Fig. 1).
Study population
A comparison will be made between the patient popula-
tions of participating and non-participating individual
GPs, located within the territories of the participating
PCNs(see 2.5). Data of participating patients will be used
to monitor level of implementation and quality of care
(see 2.6).
Patients of which data will be available correspond to
these criteria:
1. To have a GP residing within the territory of a
participating PCN, or to be domiciled there if the
patient does not have a GP;
2. To have died a ‘non-sudden death’ in the study
period (data of patients for comparison of GPs’
patient populations) and/or have a ‘positive surprise
question’ according to their GP [20] (data of
participating patients for the monitoring of quality
of care);
3. To be at least 45 years old at the moment of
inclusion.
Intervention and research procedures
GPs interested in implementing and evaluating the
CPPPC, are trained to implement the CPPPC (see The
Care Pathway for Primary Palliative Care (CPPPC)), to
fill web-based questionnaires reflecting the components
of the CPPPC and to inform and motivate patients and
their relatives to take part in the study.
For this evaluation study, the CPPPC was operational-
ized as follows:
1. Determination of a practice denominator:
participating GPs will note how many patients are
consulting them in a defined time period of 10
consecutive weekdays. For every person on this ten
days practice denominator list, GPs are asked to
answer the “surprise question” aiming to comprise a
list of people with reduced life expectancy [24].
2. Identification of patients eligible for the study:
during, but also after the determination of the
practice dominator, GPs are expected to identify
palliative care patients in an early way. For this
study, only patients of 45 years or older are eligible.
3. Introduction of Advance Care Planning:
participating GPs are asked to introduce Advance
Care Planning to eligible patients. This will happen
with or without an explicit understanding of the
palliative care situation by the palliative care patient,
Table 3 Characteristics of the five participating clusters, in chronological order of planned start [.]
Cluster Official language Nr of inhabitants [46] PCN/Palliative home care
teams situation
GP circles
1: Zone of Antwerp Dutch 765.470 One legal entity 12, of which 3 not completely
in the territory
2: Zone of Mons French 572.979 One legal entity 8, of 3 which not completely
in the territory
3: Brussels Capital Region Dutch/French 1.163.486 1 PCN, 1 Dutch-speaking and 3
French-speaking palliative
home care teams
1 Dutch-speaking + union of 19
French-speaking
4: Province of Limburg Dutch 856.280 PCN and palliative home care
teams separate, residing in
the same building
17, of which 1 not completely
in the territory
5: Province of Namur French 484.737 One legal entity 8, of which 2 not completely in
the territory
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depending of the GPs understanding of the
information needs of the patient. If deemed
appropriate by the GP, the GP will ask the patient to
sign the informed consent to take part in this study.
In the CPPPC training, it is stressed that (1) patients
found eligible can, but are not obliged to be included
and (2) that GPs should use their common sense, to
make sure that both Advance Care Planning and the
study are introduced in a sensitive way.
4. Delivery of high quality palliative care: GPs are
expected to deliver optimal quality of palliative care.
GPs are taught about the three instruments
suggested by the CPPPC as mentioned in 1.4, but in
a Belgian healthcare tradition use of these
instruments is not compulsory. GPs are asked to fill
monthly questionnaires on the PPSv2 of included
‘focus’-patients. Patients and informal care givers are
asked to fill monthly or sometimes weekly
questionnaires on the holistic aspects of the illness
trajectory and patient experience of health care.
More details are described in 2.6.
5. Ensuring high quality care for the dying and for the
bereaved: GPs are taught about warning signs
(PPSv2 score of 20 % or lower) to detect their
patients’ dying phase and about good clinical
practice in care for the dying. GPs are asked to be
creative in providing continuing (bereavement) care
for the family members when the patient has died.
One month after the death of an included patient,
both the GP and the informal care giver will be
asked to fill a questionnaire on the quality of dying
and on bereavement care.
Outcome measures (health care consumption data)
The IMA uses algorithms to identify patients for the
study population and to deliver data relevant to the re-
search questions. These data identified by the NN of all
patients in the study population (see 2.3) and NIHDI-
numbers of their GPs will be coded by an innovative
coding strategy, as explained more in detail in 2.9. This
data collection will end the 31st of December 2018, two
years and nine months after the end of Phase 6 (see
Fig. 1).
Primary outcome: reduction of hospital death rate
The primary outcome of this study is a reduction of all
hospital deaths from 50 % [30, 31] to 35 %. In Belgium,
about half of people die in the hospital, including about
5 to 10 % of deaths in a palliative care unit [30, 31].
Through health care consumption data, it can be known
which percentage of the deceased of a GP practice, in a
certain period died at home, in a nursing home, in a
hospital or elsewhere.
Secondary outcome: use of services
The secondary outcome is directing use of services to-
wards quality of life in the last year of life. The ideal
health care spending pattern is considered to be pallia-
tive home care (more contacts with GPs than with hos-
pital doctors, …), with more use of symptomatic
medication than of medication with a clear life prolong-
ing intention and reduction of stressful diagnostic and
therapeutic procedures. Indicators here, available by the
IMA, are:
– Contacts of patients with primary care: GPs, home
care nurses, physiotherapists
– Support of patients by palliative home care:
palliative forfeit, palliative home care teams
– Emergency department visits with or without GP
referral
– Length of stay in hospital, nursing home, or
palliative care unit
– Use of medication with clear curative or life
prolonging intent (e.g. statins)
– Use of symptom medication (e.g. morphine,
antidepressants)
– Selection of diagnostic procedures: common lab
tests, imaging procedures
– Selection of therapeutic procedures: blood
transfusion, ascites paracentesis, etc.
– Health care consumption costs.
Monitoring of implementation, quality of care and quality
of life (GP and patient surveys)
Participating GPs, patients and relatives will fill period-
ical web-based surveys on illness trajectory and different
Fig. 1 Stepped wedge cluster design applied in this study
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aspects of care quality. These surveys will be collected
via a secured electronic data collection system. All sur-
veys have been drafted and piloted in Dutch, and have
been back-and-forth translated to French; they are avail-
able on request.
To identify uniquely all patients involved, their NN num-
bers are used. To guarantee confidentiality of these person-
alized research data, the unique NN numbers will be coded
electronically by eHealth, the health care data coding
agency of the Belgian federal government (see 2.9 for more
details). Doing so, re-identification of patients by the ana-
lysts is impossible.
The professional NIHDI number of participating GPs
number is used for the data collection and coded by simi-
lar procedures during the data handling process, making
re-identification of the health care professional impossible.
This data collection strategy will end the 31st of
December 2016, nine months after Phase 6 (see Fig. 1).
Monitoring level of CPPPC implementation
On the regional level, the number of GPs reached by
educational sessions and regional platform meetings will
be measured, besides the quality of these educational
sessions as perceived by attending GPs and the number
of GPs interested to participate.
Participating GPs will be asked (1) to fill an 11-item base-
line survey including personal characteristics and the
10 days practice denominator and (2) to include eligible pa-
tients for the study, i.e. being older than 45 years and hav-
ing a ‘positive surprise question’ according to the GP [24].
For all included patients, the GP will fill a baseline survey
on the patient’s medical condition based on the validated
Supportive and Palliative Care Indicator Tool (SPICT)(ver-
sion June 2013) [32]. To reduce the barrier of administra-
tive overload for GPs, in this baseline survey the GP can
choose whether a single-item survey (PPSv2) will be filled
for this patient: if yes, this patient is called a ‘focus’-patient.
Per ‘focus’-patient, the GP fills a single-item survey
(PPSv2) monthly, or weekly if the PPSv2 score is becoming
30 %, or less (when the patient gets weak and life expect-
ancy decreases more) [33]. When a participating patient
dies (‘focus’-patient or not), the GP will fill a 19-item survey
on self-perceived quality of care delivered for this patient
with a self-assessment for performance and two open ques-
tions. This survey was constructed by the research team to
reflect the components of the CPPPC and has been minim-
ally validated by informal peer review. The more steps are
completed by a GP, the higher the level of involvement in
the CPPPC is considered to be.
Monitoring quality of care and quality of life
Participating patients will receive a 14-item base-line
survey to answer background questions on different psy-
chosocial, cultural and spiritual issues.
Afterwards, every person involved in the study or an
appointed relative will receive surveys about quality of life
and quality of care periodically. This 26-item survey is an
amalgam of adapted versions of the Palliative Outcome
Scale (POS) [34] and (POS-S) [35], the NIVEL quality in-
dicators for palliative care [36, 37] and a limited number
of questions related to the 7 C’s of the Gold Standard
Framework [22]. Several parts of this survey have been
validated separately, but not the sum of it. The frequency
for this questionnaire is monthly if the PPSv2 score is un-
known or more than 30 %, and weekly if the PPSv2 is
30 % or less.
After the death of a participating patient, the
appointed relative will fill a 5-item survey on perceived
quality of care during and after the dying process.
Sample size calculation
The average size of the patient population per active GP
is estimated to be approximately 1000 [15]. With a mor-
tality of 1 % per year [38], 10 patients per GP per year
are expected to die, of which 9 are expected to die non-
suddenly [39]. Pre-existing differences are expected to
exist between the patient populations of GPs. For in-
stance (although not found in literature), the age of GPs
is expected to be positively correlated with the age of his
patients, which is relevant for palliative care delivery. On
a district level, the availability of health care services
[40] and on a socio-cultural level the preferred use of
health care services also influence patient outcomes [41].
Therefore, we assume in the following power calculations
a relatedness between eligible patients within a GP patient
population expressed by an intra-class correlation coeffi-
cient of 0.2 and an average of 9 eligible patients per GP.
To detect a difference of 15 % hospital death rate be-
tween the trained and the untrained GPs, a classic ran-
domized control trial with two groups, taking into
account an intra-class correlation coefficient of 0.2,
would require a sample size about 440 GPs to reach
80 % statistical power. Thanks to the stepped wedge de-
sign implemented in this study, with 5 clusters, 5 steps
and 1 baseline measurement, the required sample size of
GPs is reduced to approximately 180, as calculated in a
recently published formula [42]. The total number of
GPs amenable in this study is approximately 3500.
Hence, a participation rate of 5 % is required. This par-
ticipation rate of 5 % is considered realistically achiev-
able, according to Rogers’ Innovation/Adoption curve
(15 % of all people are considered ‘innovators’ and ‘early
adaptors’, adapting innovations fast) [43].
Recruitment strategies
Recruitment of PCNs
Participating PCNs will have signed a collaboration
agreement (convenience sampling). The role of PCNs in
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the study, as explained in Table 2, is to facilitate the local
coordination of the project, (1) by bringing the research
team in contact with local GP circles and local GPs in-
terested in palliative care (research), (2) by organizing
educational sessions for GPs and paramedics and (3) by
supporting the logistics of both the quantitative and
qualitative data collection.
Participating PCN are paid a small financial compen-
sation for completion of these tasks.
Recruitment of GPs through educational sessions
A diversity of educational sessions is organized to inform
local GPs (and local paramedics) within the territories of
participating PCNs. A kick-off workshop is organized at
the start of the intervention in every region (see Table 2).
In this kick-off workshop, GPs and paramedics are in-
vited to attend a 3-hours program discussing the high-
lights of the CPPPC (see 1.4). This kick-off workshop
aiming for an audience of 50 to 100 participants is de-
signed to help ‘spreading the news’ to all local primary
health care professionals. This rather large-scale recruit-
ment intervention is followed by many interventions of
a smaller scale: Continued Medical Education sessions
for GPs for 10 to 50 participants during 1 to 1,5 hours
and GP office visits for mostly 1 to 10 GPs during 30 to
60 minutes. These small-scale educational sessions are
ideal to have (group) discussions on the barriers and facili-
tators to deliver palliative care in general and to promote
the CPPPC as a tool to improve palliative care practices.
GPs showing interest in the project, by attending these
educational sessions about the CPPPC, are asked to par-
ticipate in the study (convenience sampling). Participat-
ing GPs will have signed a collaboration agreement and
will know that for the first questionnaire filled and for
patients included for the project (see 2.6.1) they will be
paid a small compensation fee.
Recruitment of patients and informal care givers
Participating GPs have received minimal training on
informed consent taking for research purposes by the
research team and are asked to include eligible patients
(see 2.3) for follow-up of the intervention. GPs are
taught about the importance of having the support of
the patients’ informal care givers for the completion of
the surveys. Therefore every patient is asked to appoint
a relative for assistance. Patients are asked by their
own GPs to sign the informed consent form. Patients
and their informal care givers will not be rewarded fi-
nancially for their participation.
Linkage of health care consumption data and
questionnaire data
Both data collection systems (questionnaires from GPs
and people in the palliative care setting besides health
care consumption data) will be linked securely allowing
more in-depth analysis, taking into consideration all confi-
dentiality regulations, as promulgated by the National
Commission for the Protection of Privacy and its Sectorial
Committee of Social Security and Health Care. Therefore,
the Sectorial Committee had to give written approval in
advance with all data handling procedures as used in this
research project. (deliberation number SCSZG/13/251 dd.
19 November 2013) The acronyms used in this chapter
refer to the figures showing the data linkage process.
Coding procedure for the health care consumption data:
standard data trajectory of the IMA (see Fig. 2)
First, at the level of the HI funds, the unique NN of all
patients in the study population (see 2.3) will be trans-
formed by the security officer to the patient-pseudo code
C1. This C1 still is linked to the original health con-
sumption data and will be sent to the Trusted Third
Party (TTP) of the respective HI funds, which encrypts
the data (####) while transforming C1 to another pseudo
code C2. In the end, these encrypted data (###) paired
with the C2 pseudo code are sent to the Data Ware
House of the IMA. Here, all encrypted health care con-
sumption data are stored in a secured way. This is the
standard data trajectory of the IMA.
Selection of relevant health care consumption data for the
prospective study
The TTP of the HI funds knows which C2 of the IMA-
Data Ware House is linked to which C1. This is how the
relevant IMA data (see 2.5 for more details) can be
extracted by the TTP of the HI funds and stored in a
separate sector of the IMA Data Ware House: the Pro-
ject Data Ware House.
Fig. 2 Coding and encryption: standard data trajectory of the IMA
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The IMA analyst will now categorize IMA-data and
label the desired groups of GPs and patients(see 2.10 for
more details). For this procedure, the IMA analyst works
with research data linked to the unique project code and
with the original NIHDI-number of the GPs of the re-
search clusters. The original NIHDI-numbers are only
coded in a later stage of the coding and linkage proced-
ure because the original NIHDI-numbers are needed by
the IMA-analyst to perform the pre-analysis.
Coding procedure for the questionnaire data (see Fig. 3)
All data from the questionnaires (Qdata) initially are
linked with the personal NN of patients. For GPs, the
data are linked with their NIHDI number. Immediately
after answering, this privacy-sensitive information is sent
directly to eHealth, which will perform three actions.
First, a unique Project Random Number (PRN) to be
used only in this specific data handling procedure is linked
with the NN. The link between these two numbers will be
sent to the security officers of the different HI funds. Here
again, the unique NN will be transformed towards a pa-
tient pseudo code C1 and then sent to the Trusted Third
party (TTP) of the HI funds.
Secondly, eHealth sends the link between the PRN and
the project code, i.e. the patient-pseudo code which will
ultimately be used for analysis (Cproj), to the TTP of the
HI funds.
Finally, a third link between the project code (Cproj)
and the questionnaire data (Qdata) is sent from eHealth
to the TTP of the HI funds.
Linkage of questionnaire data and health care consumption
data (see Fig. 3)
After pre-analysis, the IMA project database (Idata) is sent
through the TTP of the HI funds to the authors’ Data
Ware House which will be used to analyze all completely
coded data, whether they come from the questionnaires
(Qdata) or from the IMA (Idata). At this last stage, the ori-
ginal patient’s NNs are replaced by project codes (Cproj)
and the doctor’s original NIHDI-numbers are replaced by
doctor pseudo codes (Cdoct). Survey and IMA data will be
linked with an estimated failure risk of max. 2-3 %.
Selection of relevant health care consumption data for the
retrospective study (see Fig. 4)
For patients not having signed an informed consent,
the inclusion and first data flows are different and ques-
tionnaire data are off course not available. The inclusion
will be done in the database of the HI funds as explained
in “2.3 Study population”.
Of these people, the NN will be sent to the security of-
ficers of the HI funds. These officers will send the NN
to eHealth. From then on, the data flow is very similar
to the one of patients with an informed consent.
Analysis
For the analysis of primary and secondary outcome mea-
sures, longitudinal and cluster analysis are to be used to
compare data of patient populations of participating GPs
vs. patient populations of non-participating GPs. If pos-
sible, the IMA will match included GPs with control
GPs based on age category (per 5 years) and GP circle. If
matching proves not to be realistically achievable, these
characteristics of the GPs will be considered independ-
ent variables.
The data related to monitoring the implementation of
the CPPPC and the quality of care and quality of life, are
to be used descriptively to contextualize the primary and
secondary outcomes related to participating GPs and pa-
tients. To be able to describe the GPs’ patient popula-
tions, data will also be available through the IMA on the
patients’ age category, gender, month of death, disease
Fig. 3 Data flow of patients having signed an informed consent (questionnaires available)
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category (cancer vs. non-cancer; presence of dementia)
and socio-economic status.
Ethical considerations
The study design has been approved by the Ethical
Commission of the University of Antwerp (number 13/
35/333, date: 7/10/2013) and by the Belgian Commission
for the Protection of Privacy (statement SCSZG/13/251,
date: 19/11/2013).
Stepped wedge cluster design
A thorough consideration of the ethical aspects of the
stepped-wedge design is important, especially for com-
munity based research when ‘informed consent’ cannot
be obtained on an individual level [44]. When it is as-
sumed that the intervention is more likely to benefit the
patient than to harm the patient, as is assumed for high
quality palliative care, the advantage of the stepped
wedge cluster design is that all clusters will have re-
ceived the intervention in the end, while still comparing
data between intervention and control groups.
Data retrieval after death
The health care consumption data are obtained with a
‘waiver of consent’, commonly used in cluster designs
analyzing coded data on community-basis [45]. A waiver
of consent is granted by an ethical committee if it is
deemed ethically reasonable, that data of persons can be
analyzed even without their explicit informed consent.
This procedure is necessary here, because of two rea-
sons: 1) these health care consumption data of deceased
persons are very relevant for the evaluation of the
CPPPC and 2) it is impossible to have an informed con-
sent of all members of the target population. In this
situation it is of utmost importance to preserve confi-
dentiality of the data.
Informed consent procedures
Both GPs and patients have to sign that they agree with
the research procedures, as explained above. GPs are
supported by the authors to collect data and to make it
to the next step in the procedures in a correct way, for
both academic and humane aspects of recruiting pa-
tients and collecting data. If a GP or a patient wants to
stop delivering data, one phone call to the PCN will be
enough to do so.
Data handling procedures
In Belgium, every new data handling procedure involv-
ing privacy-sensitive data, for instance data linked with
NN or NIHDI numbers for research, as is the case in
this evaluation study, must be approved by the National
Commission for the Protection of Privacy before use.
This approval has been granted because the procedures
rely on the safest data handling procedures available, as
explained above.
This Commission for the Protection of Privacy does
not only give advices on technical procedures, but also
on the content of information to be transferred through
the procedures.
Discussion
A general discussion of the research protocol and its ra-
tionale is followed by a further discussion of the major
advantages and disadvantages of collecting data by
means of an electronic platform, how this study design
tries to tackle the six key challenges in palliative care re-
search and how this study design fits into the Learning
Health Care System’s paradigm.
Fig. 4 Data flow of patients not having signed an informed consent (surveys not available)
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General discussion
The CPPPC is a tool to improve palliative care practices, by
starting palliative care earlier with the introduction of an-
ticipatory care planning, and by providing comprehensive
and interdisciplinary care for patients included in the Care
Pathway. Its strength seems to be its combination of
systematical assessments and patient-centeredness. The
primary outcome for this study is a reduction of
hospital-based deaths from 50 % to 35 % and the sec-
ondary outcomes are an increase of deaths at home
and an increase of health care consumptions patterns
suggesting high quality palliative care. To achieve these
objectives, the challenge to be overcome seems to be
the complexity of the CPPPC. That is why it is import-
ant to monitor GPs’ level of involvement in the study
and the patients’ appreciation of the CPPPC .
To be able to evaluate the implementation of the
CPPPC, a quasi-experimental stepped wedge cluster de-
sign has been set up. The main advantage of this trial
design is the roll-out per time period in the different
clusters, allowing the researchers more dedicated time
per cluster for the start-up of the intervention. A limita-
tion here is the fact that randomization of research clus-
ters was impossible, because not all 5 clusters were
known at the start of the project.
The recruitment strategies involving different hierarchical
levels (PCNs and GP circles on the meso-level and GPs and
patients and their informal cares on the micro-level) pro-
vide opportunities for the establishment of a research net-
work, but are expected to be time-consuming.
Qualitative methods complementing the quantitative
methods explained in this research protocol will be de-
scribed in a future article.
Table 4 Challenges for palliative care research and solutions given here
The six key challenges How this study tries to solve them
Recruitment
- Varying definitions of palliative care among clinicians and so-called
‘gate-keeping’: clinicians and family members keeping patients from
participation
- Suggesting a ‘clear’ starting point for palliative care, i.e. life-expectancy of
one year; training the GPs in communication skills specifically to obtain an
informed consent.
- Inability of patients to give informed consent - By trying to recruit patient participants in the early palliative stage.
Attrition: missing data and drop-out - By having complementary datasets. For instance, if a participating patient
stops delivering data, the authors still have access to the health
consumption data.
Differing disease categories - Distinctions will be made related to disease category in the health
consumption data and the baseline questionnaires.
Respondent burden - The researched unit is not only the patient, but also the informal
caregivers and the GP – the research team hopes that all three
components of this triangle can encourage each other in the data
collection process.
- Only to start there will be little paperwork, afterwards, an email will have
to be answered once a month.
- If a patient, the informal care giver or the GP are tired of delivering data,
they must contact the PCN to stop participating in the study; this allows
the PCN or its related palliative home care team to help participants in
clinical aspects, if appropriate and necessary.
Randomization: sometimes, randomization means denying an
intervention to patients
- The stepped wedge cluster design allows the authors to implement the
intervention in all clusters.
Outcomes - A multitude of research methods lead to a prism of outcomes pointing to
quality of palliative care. Validated questionnaires like POS and POS-S were
combined and reduced to balance importance of outcome measuring
with avoidance of respondent burden.
Table 5 Summary
What was already known on the topic:
1. Primary palliative care is an emerging field.
2. Recruitment for palliative care research and for primary care research
is a difficult process.
3. Web-based questionnaires can be used for research purposes.
4. In Belgium, health consumption data are available for research
through the InterMutualistic Agency.
What this article added to our knowledge:
1. Data linkage of personalized web-based questionnaires data and indi-
vidual health consumption data is possible in a secure way with re-
spect for confidentiality issues.
2. Electronic data coding algorithms allow researchers to use
individualized but coded health care data for assessment of complex
interventions, while respecting the privacy of included patients.
3. IT solutions could partly reduce respondent burden in health care
research.
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Major advantages and disadvantages of an electronic
data collection system
The authors want to stress the innovative nature of the
electronic data collection system. There are many advan-
tages here. Data collection occurs securely and coded
from the start onwards. The financial investment will
probably be worth it, considering all costs and practical
difficulties related to research performed in an analogue
way: printing and sending questionnaires on paper by
regular post, hoping that the questionnaires return to
the research team in a well filled and readable way, using
unique codes for linkage all the data arriving from differ-
ent sources, and at last the manual input of data. All
these aspects of research are bypassed by the electronic
data collection system.
Off course, to find palliative care patients willing to fill
web-based questionnaires is not an easy task, and to stay
motivating them to continue is expected to even be
harder. That is why the authors ask the GPs to motivate
informal care givers of these palliative care patients to
(support them to) fill the questionnaires. Still, data collec-
tion bias can be expected for ill patients and overburdened
informal care givers are expected to be less likely to fill all
surveys. Furthermore, older people (our target group) are
less likely to have access to IT-facilities.
Coping with challenges in palliative care research
According to Farquhar et al. [9], there are six key chal-
lenges in palliative care research which can be answered
by mixed methods research. Table 4 describes how this
study tries to tackle all six key challenges. Although
there was attention for these key challenges while de-
signing this study, recruitment of GPs and patients is
still expected to be time-consuming.
This approach fits in the Learning Health Care System’s
paradigm
This study uses routine health care consumption data to
describe the possible effect of this intervention aiming to
improve palliative care delivery in the community. This
approach being similar to the concepts of the Transform
Project [13], in which routine data in the primary care
Electronic Health Records (EHR) are used to find patient
EHR data for research purposes [12], fits into the ideal of
the Learning Health Care System. Doctors and patients
don’t have to do extra efforts to deliver useful data, while
the researchers and the regulating bodies guarantee the
privacy of these data. In the end, large-scale epidemio-
logical and health-economic studies will be made possible
in a feasible way [12].
Discussion and conclusion
This article explains the quantitative methods used in the
evaluation study of the CPPPC (the first evaluation study
of a primary palliative care intervention in Belgium), and
shows an innovative way of data collection and linkage in
a secure way, making it more feasible for researchers to
analyze large data sets from different sources. A summary
of this article can be read in Table 5. It is hoped for, though
not yet proven that the IT solutions used will partly reduce
respondent burden, a known problem in palliative care
research.
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